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Abstract
Background: The purpose of this study was to assess the association between leisure-time physical activity (LPA)
and the risk of metabolic syndrome (MS).
Methods: Prospective cohort studies of the association between LPA and the risk of MS were retrieved from the
PubMed and Embase databases up to 12 August 2013. The statistical analysis in this study was performed using
Stata 11.0 software. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the effect of LPA on
the risk of MS.
Results: A total of five articles were included in this meta-analysis. The overall effect sizes indicated that people with
moderate level LPA (OR = 0.89, 95% CI: 0.82 to 0.96, P = 0.003) or high level LPA (OR = 0.58, 95% CI: 0.38 to 0.89,
P = 0.012) had lower risk of MS than people with low level LPA. The subgroup analysis by gender showed that high
level LPA could reduce the risk of MS in populations of different genders (female, OR = 0.20, 95% CI: 0.08 to 0.49,
P <0.001; male, OR = 0.59, 95% CI: 0.43 to 0.82, P = 0.002). However, compared with low level LPA, Americans with
high level LPA did not significantly reduce the risk of MS (OR = 0.59, 95% CI: 0.43 to 0.82, P = 0.002), while a significant
decrease of the risk of MS was found in Europeans with high level LPA (OR = 0.49, 95% CI 0.32 to 0.77, P = 0.002) in the
subgroup analysis by region.
Conclusions: The meta-analysis confirmed that a moderate and high level of LPA could reduce the risk of MS.
Keywords: Metabolic disorder, Quantitative review, Blood pressure, Insulin resistance, Glucose intolerance,
Sensitivity analysis
Background
Metabolic syndrome (MS) is a common metabolic disorder
owing to a combination of unhealthy diet, sedentary
lifestyle and genetic predisposition [1]. Studies have
shown that it is characterized by the presence of any of
the following: abdominal obesity, dyslipidemia, low high-
density lipoprotein (HDL), elevated blood pressure,
glucose intolerance and insulin resistance [2-4]. As a
clustering of risk factors, MS is strongly associated with
the incidence of all-cause mortality, endometrial cancer,
diabetes and cardiovascular diseases [5-7]. Therefore, it is
essential to find appropriate approaches to prevent and
control MS-related diseases.
In recent years, the role of physical activity (PA) in
health has been increasingly recognized [8]. Generally, PA
is defined as any bodily movement produced by skeletal
muscles that results in energy expenditure [9]. It is well
documented that habitual leisure-time PA (LPA) could
play a preventive role in hypertension, insulin resistance,
glucose intolerance [10], elevated triglycerides, low level
HDL and MS [11]. For MS, Méndez-Hernández and
colleagues indicated that at least 30 minutes a day of LPA
at different intensity levels significantly reduced the risk of
MS among Mexican men and women [12]. However,
Cheriyath and co-workers found that LPA was weakly
associated with the incidence of MS [13]. In addition, PA
during leisure recorded in middle age prior to the current
waves of obesity and diabetes had an independent predict-
ive association with the presence of MS [14]. It is clearly
observed that inconsistent results exist in the current
studies of the association between LPA and MS. This may
be the result from the use of different definitions and the
characteristics of the included populations. To provide
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reliable and strong evidence, we conducted a meta-analysis
of prospective cohort studies with the aim to assess the
association of LPA with the risk of MS.
Methods
Search strategy
We performed pre-established search strategies and re-
trieved literature in a systematic way from the PubMed
and Embase databases with a retrieval deadline of 12
August 2013. The keywords used for searching included
three aspects: 1) exposure factors (‘physical activity’,
‘leisure-time physical activity’, ‘occupational physical
activity’ and ‘sport’); 2) MS (‘metabolic syndrome’, ‘MetS’,
‘MS’, ‘metabolic syndrome X’, ‘syndrome X’, ‘cardio meta-
bolic risk factor’ and ‘insulin resistance syndrome’); and 3)
study type (‘prospective’, ‘cohort’ and ‘follow up’). In
addition, a manual search of paper literature from rele-
vant original studies, the screening of references and the
included studies from the related reviews were performed
to obtain additional studies.
Inclusion and exclusion criteria
The studies included in the present meta-analysis met the
following criteria: 1) the studies were prospective cohort
studies; 2) the study subjects were healthy; 3) the study
was designed to assess the effect of PA on the risk of MS;
4) the control group comprised individuals with a low
level of PA; and 5) the available data should be provided
or calculated out from the data of the studies. The studies
were excluded if: 1) the language of the studies was not
English; and 2) articles were reviews, letters and com-
ments. In addition, for repeatedly published literature, the
studies with the most complete data were included in this
meta-analysis.
Data abstraction and quality evaluation
Two evaluators independently selected studies and ex-
tracted data. Discrepancies were resolved by discussion
with each other. From the studies that met the inclusion
criteria, the following data were abstracted: the first
author’s name, year of publication, region, year of the
study, duration of follow-up, ascertainment of LPA level,
diagnostic criteria of MA, age and gender of the subjects,
sample size in each group and the data of statistical
analysis.
The quality of the included studies was evaluated ac-
cording to the Newcastle-Ottawa Scale [15]. This scoring
system for cohort studies comprised eight scoring items:
representativeness of the exposed cohort, selection of
the unexposed cohort, ascertainment of exposure, outcome
of interest not present at start of study, control for im-
portant factor or additional factor, outcome assessment,
follow-up long enough for outcomes to occur and ad-
equacy of follow-up of cohorts. The score of each item
was 1, except for the item of control for important factor
or additional factor, which was 2. Thus, the total score
was nine. The studies with a score of more than 7 were
considered high quality studies.
Statistical analysis
The statistical analysis in this study was performed using
Stata 11.0 software (StataCorp LP, College Station, TX,
USA). The odds ratio (OR) as well as the corresponding
95% confidence intervals (CIs) in each study were pooled
to assess the association between LPA and the risk of
MS [16]. Heterogeneity among studies was evaluated by
Cochran’s Q test and the I2 parameter [17]. P <0.05 and
I2 > 50% were considered to be heterogeneous. When
significant heterogeneity was detected in the studies, the
random effects model was used to pool the data. Other-
wise, the fixed effects model was used. The subgroup
analysis was conducted by gender (male/female) and re-
gion (Europe/the Americas) to investigate the influence
of these confounding factors on the outcomes of this
meta-analysis.
A sensitivity analysis was performed to detect stability
and credibility of the outcomes by changing the effects
model and the trim-and-fill method [18]. Publication
bias was assessed by the funnel plot with Begg’s and




According to the initial search strategy, we achieved 838
and 550 articles from the Embase and PubMed libraries,
respectively. First, a total of 227 repeated and 1,131 ob-
viously irrelevant articles were excluded. Among the
remaining 30 studies, we reviewed the titles, abstracts
and the full texts. Finally, five articles met the screen-
ing criteria and were included in this meta-analysis
[12-14,21,22]. There were no additional articles obtained
from the manual search (Figure 1).
Study characteristics and quality assessment
The characteristics of the included studies are shown in
Table 1. Among the five included studies, the subjects in
the studies of Méndez-Hernández et al. [12] and Yang et al.
[21] consisted of male and female populations. Thus, a total
of seven studies were included in this meta-analysis. The
LPA level was obtained and assessed by self-administered
questionnaires during follow-up. The diagnostic criteria of
MS were in accordance with the new National Cholesterol
Education Program’s (NCEP’s) Adult Treatment Program
III (ATP III) in the study of Cheriyath et al. [13]. The other
four studies [12,14,21,22] diagnosed MS according to the
original NCEP ATP III. The total sample size of the five
articles was 22,023 including 5,084 MS cases. Moreover,
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the quality evaluation of the included articles is shown in
Table 2. All the included literatures were of high quality as
they scored 7.
Meta-analysis
LPAs were divided into three levels (low level LPA,
moderate level LPA and high level LPA) in three in-
cluded studies [21-23]. In the study of Holme et al.
[14], the moderately and moderately vigorous levels of
LPA were considered as moderate level LPA. The study
of Méndez-Hernández et al. [12] only had low level
and moderate level LPA groups. Thus, there were eight
sets of data for moderate level LPA versus low level
LPA and five sets of data for high level LPA versus low
level LPA.
For the moderate level LPA versus low level LPA,
the statistical heterogeneity among the studies was not
significant (I2 = 19.9%, P = 0.272) (Figure 2), thus the
fixed effects model was used. The pooled OR of the
moderate level LPA versus low level LPA was 0.89
(95% CI: 0.82 to 0.96, P = 0.003). This indicated that
the effect of moderate level LPA on reducing the risk
of MS was more significant than the low level LPA.
For the high level LPA versus low level LPA, the sig-
nificant heterogeneity (I2 = 75.0%, P = 0.003) (Figure 3)
among studies was found and the random effects
model was used. The overall OR of the high level LPA
versus low level LPA (OR = 0.58, 95% CI: 0.38 to 0.89,
P = 0.012) demonstrated that high level LPA signifi-
cantly decreased the risk of MS compared with low
level LPA.
Subgroup analysis
The subgroup analysis by region and gender for the high
level LPA versus low level LPA is shown in Table 3. Fe-
male (OR = 0.20, 95% CI: 0.08 to 0.49, P <0.001) and male
(OR = 0.59, 95% CI: 0.43 to 0.82, P = 0.002) with high level
LPA all have lower risk of MS than with low level LPA.
In the subgroup analysis by region, compared with the
Europeans with low level LPA, the risk of MS was sig-
nificantly reduced in Europeans with high level LPA
(OR = 0.49, 95% CI: 0.32 to 0.77, P = 0.002). There was
no significant difference in the risk of MS among the
Americans with high level LPA and low level LPA
(OR = 0.59, 95% CI: 0.43 to 0.82, P = 0.002).
Sensitivity analysis
In the sensitivity analysis, no additional studies were
found by the application of the trim-and-fill method. For
the moderate level LPA versus low level LPA, the pooled
OR obtained by the random effects model was 0.88 (95%
CI: 0.80 to 0.96, P = 0.005). For the high level LPA versus
low level LPA, the pooled OR calculated by the fixed
effects model was 0.82 (95% CI: 0.72 to 0.93, P = 0.002).
It indicated that the results of this meta-analysis were
not varied in the sensitivity analysis. The stability of
the results of this study was confirmed by the sensitivity
analysis.
Publication bias
There was no indication of publication bias based on the
Egger’s (P = 0.536) and Begg’s test (P = 0.196).
Figure 1 Literature search and study selection. CI, confidence interval; OR, odds ratio; PA, physical activity.
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NCEP ATP III Sedentary/light 40 to 49 M 337/1,112 1.0 Age, education, triglycerides,
smoking, glucose, BMI, treated
hypertension and SBP in
1972/1973.
Moderate 967/3,807 0.98 (0.83
to 1.17)
Moderately vigorous 269/1,319 0.83 (0.67
to 1.02)








NCEP ATP III <270 min/week 42, 48, 54, 60 M Total: 1.0 Age, BMI, SBP, DBP,
antihypertensive medications,
glucose, family history of diabetes,















Low 45 to 64 M and F 641/2,366 1.00 Age, race, gender, education,
smoking, prevalent coronary
heart disease, total cholesterol
and obesity.
Middle 975/3,845 0.99 (0.86
to 1.13)








NCEP ATP III <30 min/day 20 to 70 Total: 1.00 Age, calories and alcohol intake,
smoking, work-place physical









NCEP ATP III Inactive 15, 18, 21, 24,
27, 30
Total: 1.00 Age, smoking and education.









AHA, American Heart Association; ATP III, Adult Treatment Program III; BMI, body mass index; CI, confidence interval; DBP, diastolic blood pressure; F, female; LPA, leisure-time physical activity; M, male; MS, metabolic














































Holme et al. (2007) [14] ✩ ✩ - ✩ ✩✩ ✩ ✩ - 7
Laaksonen et al. (2002) [22] ✩ ✩ - ✩ ✩✩ ✩ - ✩ 7
Cheriyath et al. (2010) [13] ✩ ✩ - ✩ ✩✩ ✩ - ✩ 7
Méndez-Hernández et al. 2009 [12] ✩ ✩ - ✩ ✩✩ ✩ - ✩ 7
Yang et al. 2008 [21] ✩ ✩ - ✩ ✩✩ ✩ - ✩ 7





















MS is highly prevalent in populations around the world.
Physical inactivity is one of the major modifiable risk
factors for MS [24]. In this meta-analysis, we assessed
the association between LPA and the risk of MS. The
results indicated that moderate level LPA and high level
LPA could decrease the risk of MS. The sensitivity ana-
lysis provided evidence for the stability of the results in
this study. Consistent results were also obtained in some
other published studies. Yu et al. reported that PA is
associated with a reduced risk of MS among Chinese
people [25]. Another article reported that the low levels
of childhood PA and aerobic fitness are associated with
the presence of MS in adolescents [26]. It suggested that
PA needs to begin in childhood to prevent MS.
The subgroup analysis demonstrated that there was no
difference in the risk of MS among Americans with high
level LPA and low level LPA. The result was different
from that in Europeans. The heterogeneity among the
studies was weakened in the subgroup analysis. Thus,
the difference of region may be one of the sources of
heterogeneity. However, the heterogeneity still existed
in the subgroup analysis. Further studies need to be
undertaken to explore the sources of heterogeneity.
It was reported that regular PA should be performed
more frequently (3 to 5 days per week) and for a longer
Figure 2 Forest plots for the risk of MS associated with the moderate level LPA. CI, confidence interval; LPA, leisure-time physical activity;
MS, metabolic syndrome, OR, odds ratio.
Figure 3 Forest plots for the risk of MS associated with the high level LPA. CI, confidence interval; LPA, leisure-time physical activity; MS,
metabolic syndrome, OR, odds ratio.
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duration (up to 60 minutes) at a lower intensity (ap-
proximately 40% to 60% VO2max) for metabolic benefits
[22,27-29]. PA is a complex and multi-dimensional behav-
ior and affects total energy expenditure which is the sum
of the basal metabolic rate [30]. It is well known that PA
can reduce fat mass. Even when an exercise program
produces no loss in bodyweight, substantial reductions
in abdominal subcutaneous and visceral fat can be achieved
[31]. Aerobic exercise training also produces favorable
changes in plasma lipids and lipoproteins [32]. Miles et al.
reported that exercise training would alter cholesterol and
low-density lipoprotein (LDL) cholesterol when changes in
bodyweight and dietary fat reduction are also achieved from
the intervention [30]. The study of Hardman et al. showed
that vasodilation of the arterioles in the exercising muscles
would cause a decrease in peripheral resistance [33].
When exercise ceases, cardiac output quickly falls back
to pre-exercise levels, but the vasodilation and decrease
in peripheral resistance persists for hours [31]. There-
fore, it is not surprising in the meta-analysis of 72 trials
that endurance training for ≥4 weeks induced significant
net reductions of resting and daytime ambulatory blood
pressure [34]. In addition, near-daily PA demonstrated
positive effects on the immune response [35]. In sum-
mary, the association of PA with a reduced risk of MS
might relate to energy expenditure, fat mass and blood
pressure reduction, and enhance the immune response.
There were some advantages of this meta-analysis. The
included studies were all high quality studies and they
were all prospective cohort studies. Thus, selection bias
and recall bias were avoided to a certain extent. There was
no publication bias in the included studies. The results of
this meta-analysis were reliable and stable according to
the sensitivity analysis.
Some limitations of this study should be discussed.
The first limitation was that the articles included were
all observational studies. Although we regulated the con-
founding factors (age, education and smoking) in these
studies, the association between LPA and MS would be
affected. Further studies are needed to verify the effects of
these confounding factors on the results of this study. Sec-
ond, the PA levels were ascertained by self-administered
questionnaires during the follow-up. There were no uni-
fied criteria for the level of PA. Thus, the effect of different
levels of PA on the risk of MS could not be evaluated.
Third, the subjects with high levels of LPA generally
had a healthy lifestyle. For them, the intake of dietary
fiber, vitamins and other nutrients, which might contrib-
ute to maintain metabolic functions and increase the pre-
ventive effect against MS, was high. This may affect the
investigation of the association between LPA and the risk
of MS. Furthermore, the included studies were carried out
in Europe and America. It is necessary to develop investi-
gations in Asian countries to assess the versatility of the
results in this study.
Conclusions
In conclusion, moderate and high level LPA significantly
decreases the risk of MS. However, more cross-sectional
studies with large sample sizes should be carried out to ver-
ify this conclusion and further investigate the association
between PA and MS by a more scientific approach.
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Table 3 Forest plots for the risk of MS associated with high level LPA
Group Number of studies OR (95% CI) Heterogeneity test Significance test (P)
P I2 (%)
All studies 5 0.58 (0.38 to 0.89) 0.003 75.0 0.012
Area
Europe 4 0.49 (0.32 to 0.77) 0.112 50.0 0.002
The Americas 1 0.90 (0.78 to 1.03) - - 0.137
Gender
Male 3 0.59 (0.43 to 0.82) 0.578 0.0 0.002
Female 1 0.20 (0.08 to 0.49) - - <0.001
Male and female 1 0.90 (0.78 to 1.03) - - 0.137
CI, confidence interval; LPA, leisure-time physical activity; MS, metabolic syndrome; OR, odds ratio.
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